Literatur
Noordman BJ et al. J Clin Oncol. 2018;36(3):268–75
Shapiro J e Lancet Oncol. 2015;16(9):1090–8
van Hagen P et al. N Engl J Med. 2012;366(22):2074–84
Gilbert A et al. Gynecol Oncol. 2015;136(3):429–39
Blazeby JM et al. Cancer. 2005;103(9):1791–9
Shapiro J et al. Ann Surg. 2014;260(5):807–13;discussion 813-4
Schandl A et al. Eur J Cancer. 2016;69:43–50
Noordman BJ et al. Ann Oncol. 2018;29(2):445–51
Al-Batran SE et al. Lancet Oncol. 2016;17(12):1697–1708
Hoeppner J et al. BMC Cancer. 2016 Jul 19;16:503
Literatur
Noordman BJ et al. Effect of Neoadjuvant Chemoradiotherapy on Health-Related Quality of Life in Esophageal or Junctional Cancer: Results From the Randomized CROSS Trial. J Clin Oncol. 2018;36(3):268–75
Author information
Authors and Affiliations
Corresponding author
Additional information
Erstpubliziert in Strahlenther Onko. 2018;194(8):794-6
Rights and permissions
About this article
Cite this article
Luttke, M., Nicolay, N.H. Keine Verschlechterung der postoperativen Lebensqualität durch neoadjuvante RCT. Info Onkol. 21, 20–21 (2018). https://doi.org/10.1007/s15004-018-6213-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15004-018-6213-2